// App-Quantinova.ai

693 : Oncogenic and osteolytic function of histone demethylase NO66 in castration resistant prostate cancer

Researchers

Presenter

  • Rozita Bagheri-Yarmand

Principal Investigators

  • Nora Navone

  • Xinhai Wan

  • Christopher Logothetis

  • Johnny Huard

  • Krishna Sinha

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • UT Health Science Center, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

  • Bone metastases

  • Solid malignancies

Biomarkers

  • Nucleolar protein 66

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved